Three-month data from ARCT-154 booster trial show persistent neutralizing antibody activity against multiple variants of SARS-CoV-2 SAN DIEGO--(BUSINESS WIRE)--Please replace the graphic with the ...
A recent study by scientists at Celentyx Ltd, the University of Birmingham, and the University of Warwick and posted to the bioRxiv* preprint server illustrated a cell-based severe acute respiratory ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced today that enrollment for the Phase I clinical study of BAT2022 has ...
Imagine the last time you went to the doctor feeling miserable with a cold. If you have ever heard “you have a virus” from your physician, you know exactly what that means. There are no antibiotics ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019, ultimately causing a rapidly spreading wave of infections that affected the world. Spanning a wide spectrum ...
(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...
The benefits of globalization have ushered in the reality of fast-spreading infectious diseases. This has made the quick development of preventive vaccines and immune therapies imperative. Spread of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback